Research and Markets Report Delves into Lung Cancer Test Development
Research and Markets has announced the addition of the “The Top 20 Developers of Molecular Diagnostic Tests for Lung Cancer” report to their offering.
Read MoreSearch Results for: lung cancer
New Study Demonstrates Clinical Validity of Lung Cancer Test EarlyCDT-Lung
Posted by Clinical Lab Products | Aug 9, 2010 | Cancer, Miscellaneous |
Oncimmune (USA) LLC, provider of EarlyCDT-Lung, announces the publication of a study that demonstrates the clinical validity of the test.
Read MoreNew Data Indicate Effectiveness of Clarient’s Pulmotax for Lung Cancer
Posted by Clinical Lab Products | Apr 22, 2010 | Cancer, Miscellaneous |
Clarient Inc has announced that data from a new study suggest that the Clarient Insight Dx Pulmotax assay may effectively predict which lung cancer patients will respond favorably to chemotherapy.
Read MoreBATTLE Links Potential Biomarkers to Drugs for Lung Cancer
Posted by Clinical Lab Products | Apr 21, 2010 | Cancer, Miscellaneous |
The first lung cancer clinical trial to guide targeted therapies to patients based on molecular signatures in tumor biopsies is a step toward personalized care and more effective, efficient clinical trials for new drugs, study leaders reported.
Read MoreClarient Launches New Lung Cancer Test
Posted by Clinical Lab Products | Feb 12, 2010 | Cancer, Miscellaneous |
Clarient Inc, a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, has announced the commercial launch of a new lung cancer test, Clarient Insight Dx Pulmotype.
Read More